Sponsor study identifier
Secondary identifiers
observational
118
1 country
1
Study Start
April 9, 2009
Actual (reported)Primary Completion
September 2, 2020
Actual (reported)Study Completion
November 16, 2020
Actual (reported)Background:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 16, 2020
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 9, 2009
Actual (reported)April 10, 2009
Actual (reported)April 13, 2009
Actual (reported)September 2, 2020
Actual (reported)November 16, 2020
Actual (reported)Endometrial Cancer, ovarian cancer
Histologically confirmed endometrial or ovarian cancer
1 year
With endometrial cancer, ovarian cancer, and women undergoing hysterectomy for benign reasons.
Women with endometrial cancer, ovarian cancer, and women undergoing hysterectomy for benign reasons.
Mayo Clinic, Rochester
Rochester, Minnesota, 55905, United States
Ries LA. Ovarian cancer. Survival and treatment differences by age. Cancer. 1993 Jan 15;71(2 Suppl):524-9. doi: 10.1002/cncr.2820710206.
Buys SS, Partridge E, Greene MH, Prorok PC, Reding D, Riley TL, Hartge P, Fagerstrom RM, Ragard LR, Chia D, Izmirlian G, Fouad M, Johnson CC, Gohagan JK; PLCO Project Team. Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial. Am J Obstet Gynecol. 2005 Nov;193(5):1630-9. doi: 10.1016/j.ajog.2005.05.005.
Nicolas Wentzensen, M.D.
National Cancer Institute (NCI)
118 participants (actual enrollment reported by the registry).
First Submitted
April 10, 2009
First Posted
April 13, 2009
Study Start
April 9, 2009
Actual (reported)The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons
Contact the study team to confirm eligibility.
Vine MF, Ness RB, Calingaert B, Schildkraut JM, Berchuck A. Types and duration of symptoms prior to diagnosis of invasive or borderline ovarian tumor. Gynecol Oncol. 2001 Dec;83(3):466-71. doi: 10.1006/gyno.2001.6411.
Primary Completion
September 2, 2020
Actual (reported)Study Completion
November 16, 2020
Actual (reported)Last Updated
November 17, 2020
Record last verified: 2020-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: